Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells
- PMID: 17942940
- DOI: 10.1158/0008-5472.CAN-07-0573
Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells
Abstract
The liver represents a major and frequently sole site of metastases for many types of cancer, particularly gastrointestinal cancers. We showed previously that coadministration of an engineered hepatic-targeting Listeria monocytogenes (LM) with a cancer vaccine enhanced the antitumor effect of vaccine-induced T cells selectively against hepatic metastases. Here, we show that administration of multiple doses of LM, in the absence of vaccine, generates therapeutic responses against hepatic metastases. LM treatment of mice bearing hepatic metastases induced tumor-specific CD8+ T-cell responses that were enhanced by depletion of regulatory T (Treg) cells by either anti-CD25 or cyclophosphamide treatment. Antitumor activity of LM further depended on natural killer (NK) cell activation but was inhibited by presence of a subset of NK T cells. These results show the utility of LM in the treatment of hepatic metastases even in the absence of vaccine administration and further suggest that blockade of Treg cells and NK T cells will enhance antitumor activity.
Similar articles
-
Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes.Cancer Res. 2006 Jan 15;66(2):1096-104. doi: 10.1158/0008-5472.CAN-05-2307. Cancer Res. 2006. PMID: 16424046
-
Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.Oncol Rep. 2009 Aug;22(2):337-43. Oncol Rep. 2009. PMID: 19578774
-
Attenuated Listeria infection activates natural killer cell cytotoxicity to regress melanoma growth in vivo.Microbiol Immunol. 2008 Feb;52(2):107-17. doi: 10.1111/j.1348-0421.2008.00018.x. Microbiol Immunol. 2008. PMID: 18380808
-
Multiple roles for CD4+ T cells in anti-tumor immune responses.Immunol Rev. 2008 Apr;222:129-44. doi: 10.1111/j.1600-065X.2008.00616.x. Immunol Rev. 2008. PMID: 18363998 Review.
-
[Listeria monocytogenes: a dangerous pathogen used as a vector for the new generation of vaccines].Vopr Med Khim. 2000 May-Jun;46(3):256-64. Vopr Med Khim. 2000. PMID: 11033885 Review. Russian.
Cited by
-
Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients.Ann Surg Oncol. 2014 Dec;21 Suppl 4(Suppl 4):S546-54. doi: 10.1245/s10434-014-3564-2. Epub 2014 Feb 22. Ann Surg Oncol. 2014. PMID: 24562936 Free PMC article.
-
Expansion of CD14(+)CD16(+) monocytes is related to acute leukemia.Int J Clin Exp Med. 2015 Aug 15;8(8):12297-306. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26550139 Free PMC article.
-
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer.J Transl Med. 2013 Apr 4;11:89. doi: 10.1186/1479-5876-11-89. J Transl Med. 2013. PMID: 23557194 Free PMC article.
-
Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer.Front Immunol. 2018 Dec 21;9:3018. doi: 10.3389/fimmu.2018.03018. eCollection 2018. Front Immunol. 2018. PMID: 30622535 Free PMC article. Review.
-
Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.Ann Surg Oncol. 2012 Jul;19 Suppl 3(Suppl 3):S597-607. doi: 10.1245/s10434-011-2037-0. Epub 2011 Oct 7. Ann Surg Oncol. 2012. PMID: 21979110 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
